Major shareholder perspective

Nomura SPARX Investment, Inc.

See the latest disclosed position by target company, then review the holder's filing history.

Search major shareholders

Not necessarily a current position

Values reflect the last required disclosure. Changes that no longer trigger a filing—such as further sales after falling below 5%—may not be reflected.

Target companies

1

Average displayed ratio

7.71%

Borrowing disclosed

0

東京

Base date Jun 14, 2024

ＣｈｏｒｄｉａＴｈｅｒａｐｅｕｔｉｃｓ株式会社

純投資（資産運用契約に基づく、顧客資産の運用）

7.71%

Company details Filing